Patent · US Active

Atrial fibrillation mapping using atrial fibrillation cycle length (AFCL) gradients

US11160481B2 · kind B2 · utility

1Cited by
0References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 22, 2018
Grant dateNov 2, 2021
Priority date
Expiry dateMar 2, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61B2018/00839
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

A method including calculating, at multiple intra-cardiac locations, respective average atrial fibrillation cycle-length (AFCL) values. A determination is made as to whether the calculated average AFCL values are indicative of a regular atrial fibrillation (AF) activity. Gradients between pairs of the average AFCL values are calculated for a plurality of average AFCL values that are determined to be indicative of regular AF activity. The calculated AFCL gradients are presented to a user, overlaid on a map of at least a portion of the heart.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.